Amphastar Pharmaceuticals, Inc. (AMPH) insider trading.
In Q3 2026, insiders at Amphastar Pharmaceuticals, Inc. reported 8 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $764K.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 5
- Net shares, P minus S
- -33,479
- Insiders
- 4
- Last filed
- 2026-09-23
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Peters William J | Director, Officer · CFO, EVP & TREASURER | 3 | 0 | 2 |
| Zhou Rong | Officer · SENIOR EVP, PRODUCTION CENTER | 3 | 0 | 2 |
| Prins Richard K | Director | 1 | 0 | 1 |
| Pierce Anthony T | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-21 | Peters William J | S (D) | 4,139 | $25 | 168,707 | Form 4 |
| 2026-09-16 | Zhou Rong | S (D) | 10,000 | $23.94 | 169,203 | Form 4 |
| 2026-09-16 | Zhou Rong | M (A) | 10,000 | $13.35 | 179,203 | Form 4 |
| 2026-09-02 | Zhou Rong | S (D) | 3,187 | $23.63 | 169,203 | Form 4 |
| 2026-08-11 | Prins Richard K | S (D) | 7,973 | $20.3 | 29,625 | Form 4 |
| 2026-08-07 | Peters William J | M (A) | 5,053 | $19.79 | 181,026 | Form 4 |
| 2026-08-07 | Peters William J | S (D) | 8,180 | $22.48 | 172,846 | Form 4 |
| 2026-07-09 | Pierce Anthony T | A (A) | 7,886 | $0 | 7,886 | Form 4 |
Transaction codes in this quarter
Get AMPH insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1297184&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · AMPH company page · Amphastar Pharmaceuticals, Inc. on SEC.gov
Questions
Are insiders buying or selling Amphastar Pharmaceuticals, Inc. (AMPH)?
In Q3 2026, insiders at Amphastar Pharmaceuticals, Inc. reported 8 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $764K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Amphastar Pharmaceuticals, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/amph.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.